Edition:
United States

Aethlon Medical Inc (AEMD.OQ)

AEMD.OQ on NASDAQ Stock Exchange Capital Market

1.49USD
20 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.49
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
78,556
52-wk High
$5.17
52-wk Low
$0.80

Chart for

About

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's... (more)

Overall

Beta: 2.22
Market Cap(Mil.): $21.20
Shares Outstanding(Mil.): 14.32
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 50.44 16.73
EPS (TTM): -- -- --
ROI: -- 14.12 35.60
ROE: -- 16.71 17.23

BRIEF-Aethlon Medical Announces Fiscal 2018 Third Quarter Results

* AETHLON MEDICAL ANNOUNCES FISCAL 2018 THIRD QUARTER RESULTS

Feb 01 2018

BRIEF-Aethlon Medical Says Granted U.S. Patent That Broadens Protection For The Aethlon Hemopurifier

* AETHLON MEDICAL ANNOUNCES ALLOWANCE OF U.S. PATENT THAT BROADENS PROTECTION FOR THE AETHLON HEMOPURIFIER® TO TREAT VIRAL INFECTIONS Source text for Eikon: Further company coverage:

Jan 18 2018

BRIEF-Sabrina Johnson Joins Aethlon Medical's Board Of Directors

* SABRINA MARTUCCI JOHNSON JOINS AETHLON MEDICAL'S BOARD OF DIRECTORS Source text for Eikon: Further company coverage:

Jan 10 2018

BRIEF-Aethlon Medical Names Dr. Charles J. Fisher Chairman Of The Board

* AETHLON MEDICAL NAMES DR. CHARLES J. FISHER CHAIRMAN OF THE BOARD Source text for Eikon: Further company coverage:

Nov 29 2017

BRIEF-Aethlon Medical announces second quarter results

* Aethlon Medical announces fiscal 2018 second quarter results

Nov 02 2017

BRIEF-AETHLON MEDICAL ANNOUNCES PRODUCTION COLLABORATION WITH IBIO INC

* AETHLON MEDICAL ANNOUNCES LARGE-SCALE PRODUCTION COLLABORATION

Oct 16 2017

BRIEF-IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL

* IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL

Oct 16 2017

BRIEF-Intracoastal Capital reports 5.7 pct passive stake in Aethlon Medical

* Intracoastal Capital LLC reports 5.7 percent passive stake in Aethlon Medical Inc as of Oct 2 - SEC filing‍​ Source : (http://bit.ly/2ybZng4) Further company coverage:

Oct 11 2017

BRIEF-Aethlon Medical Receives expedited access pathway designation from FDA

* Aethlon Medical receives expedited access pathway designation from FDA to accelerate U.S. access to the hemopurifier as a treatment for life-threatening viruses Source text for Eikon: Further company coverage:

Sep 12 2017

Earnings vs. Estimates